Skip to main content

Nuvalent, Inc.

NUVLDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001861560

Nuvalent, Inc. was delisted in 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Nuvalent, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
4 insiders, $8.91M in total
Insiders trading
4
Net value
−$8.91M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Nuvalent, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Nuvalent, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Deerfield Management Company, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20263
Deerfield Mgmt L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Partners, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Flynn James EDirector, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20263
Deerfield Healthcare Innovations Fund, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Mgmt HIF, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Private Design Fund IV, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Mgmt IV, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Meyers Michael L.Director0Jul 15, 20262
Balcom AlexandraChief Financial Officer0Jul 15, 202614
Srivastava SapnaDirector0Jul 15, 20262
Oliger Christy J.Director0Jul 15, 20262
Squarer RonDirector0Jul 15, 20263
Turner Christopher DurantChief Medical Officer0Jul 15, 20262
Noci DarleneChief Development Officer0Jul 15, 202614
Lane BenjaminSee Remarks0Jul 15, 20262
Pelish Henry E.Chief Scientific Officer0Jul 15, 20268
Porter James RichardPresident and CEO0Jul 15, 20269
Miller Deborah AnnChief Legal Officer0Jul 15, 202612
Protopapas AnnaDirector0Jul 15, 20262
Bogle Grant C.Director0Jul 15, 20262
Wheeler CameronDirector0Jul 15, 20262
Shair MatthewDirector201,672IndirectNov 26, 20252
Pearlberg JosephDirector5,146Jun 20, 20250
Hack Andrew A. F.Director1,447,267IndirectDec 13, 20240
Conley EmilyDirector2,507Aug 27, 20240
Gilliland Dwight GaryDirector2,499Jun 14, 20240
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.10% Owner897,671Aug 3, 20210
Jackson Robert BowersDirector–Jul 30, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 10, 2026 (view filing)4:30 PM ETJul 91 dayPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−2.11K$123.81−$261.4K−3.2%63.5K after10b5-1
Jul 8, 2026 (view filing)4:30 PM ETJul 62 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−30.0K$123.72−$3.71M−8.5%324.9K after10b5-1
Jul 6, 2026 (view filing)4:31 PM ETJul 15 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−23.0K$123.59−$2.84M−28.4%58.1K after10b5-1
Jul 6, 2026 (view filing)4:30 PM ETJul 15 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−11.4K$123.58−$1.41M−11.8%85.5K after10b5-1
Jul 1, 2026 (view filing)4:30 PM ETJun 292 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−5.50K$123.51−$679.3K−8.6%58.1K after10b5-1
Jun 11, 2026 (view filing)Jun 92 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−20.0K$122.81−$2.46M−25.6%58.1K after10b5-1
Jun 10, 2026 (view filing)Jun 82 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−30.0K$88.53−$2.66M−8.5%324.9K after3 lots10b5-1
Jun 3, 2026 (view filing)Jun 12 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−11.4K$98.69−$1.13M−11.8%85.5K after8 lots10b5-1
Jun 1, 2026 (view filing)May 284 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−5.50K$107.84−$593.1K−8.4%59.6K after4 lots10b5-1
Jun 1, 2026 (view filing)May 284 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−5.50K$107.80−$592.9K−8.6%58.1K after5 lots10b5-1
May 6, 2026 (view filing)May 42 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−30.0K$101.69−$3.05M−8.5%324.9K after5 lots10b5-1
May 5, 2026 (view filing)May 14 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−11.4K$99.00−$1.13M−11.8%85.5K after3 lots10b5-1
May 1, 2026 (view filing)Apr 301 dayMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−5.50K$99.22−$545.7K−8.4%59.6K after2 lots10b5-1
May 1, 2026 (view filing)Apr 292 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−5.50K$99.55−$547.5K−8.6%58.1K after3 lots10b5-1
Apr 13, 2026 (view filing)Apr 94 daysPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−3.09K$104.48−$323.2K−4.5%65.6K after2 lots10b5-1
Apr 8, 2026 (view filing)Apr 62 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−30.0K$103.77−$3.11M−8.5%324.9K after4 lots10b5-1
Apr 3, 2026 (view filing)Apr 12 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−11.4K$105.21−$1.20M−11.8%85.5K after3 lots10b5-1
Apr 1, 2026 (view filing)Mar 302 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−5.50K$97.81−$537.9K−8.6%58.1K after2 lots10b5-1
Mar 30, 2026 (view filing)Mar 264 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−5.50K$98.73−$543.0K−8.4%59.6K after3 lots10b5-1
Mar 26, 2026 (view filing)Mar 24-252 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−25.1K$98.15−$2.47M−22.7%85.5K after4 lots10b5-1
Mar 16, 2026 (view filing)Mar 12-134 daysPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−35.1K$98.08−$3.44M−34.9%65.6K after6 lots10b5-1
Mar 10, 2026 (view filing)Mar 64 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−30.0K$98.99−$2.97M−8.5%324.9K after3 lots10b5-1
Mar 2, 2026 (view filing)Feb 264 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−5.50K$103.03−$566.7K−8.6%58.1K after3 lots10b5-1
Mar 2, 2026 (view filing)Feb 264 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−5.50K$103.05−$566.8K−8.4%59.6K after3 lots10b5-1
Feb 2, 2026 (view filing)Jan 294 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−5.50K$102.08−$561.4K−8.6%58.1K after4 lots10b5-1
Jan 23, 2026 (view filing)Jan 21-222 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−15.0K$110.15−$1.65M−20.1%59.6K after2 lots10b5-1
Jan 7, 2026 (view filing)Jan 5-62 daysPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−5.16K$97.24−$501.8K−7.3%65.9K after7 lots10b5-1
Jan 7, 2026 (view filing)Jan 5-62 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−7.42K$97.25−$721.3K−15.4%40.6K after7 lots10b5-1
Jan 7, 2026 (view filing)Jan 5-62 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−6.95K$97.26−$676.2K−14.2%42.1K after7 lots10b5-1
Jan 7, 2026 (view filing)Jan 5-62 daysTurner Christopher DurantChief Medical OfficerSSaleClass A Common Stock−7.42K$97.25−$721.3K−11.9%55.1K after7 lots10b5-1
Jan 7, 2026 (view filing)Jan 5-62 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−7.42K$97.25−$721.3K−8.3%81.7K after7 lots10b5-1
Jan 7, 2026 (view filing)Jan 5-62 daysPorter James RichardPresident and CEOSSaleClass A Common Stock−27.4K$97.26−$2.67M−9.0%278.6K after7 lots10b5-1
Jan 5, 2026 (view filing)Jan 23 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−10.0K$100.51−$1.01M−16.9%49.1K after3 lots10b5-1
Jan 2, 2026 (view filing)Dec 30, 20253 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.00K$100.04−$400.2K−7.7%48.0K after2 lots10b5-1
Dec 10, 2025 (view filing)Dec 82 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−7.08K$110.32−$781.5K−11.5%54.6K after2 lots10b5-1
Dec 2, 2025 (view filing)Nov 284 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.00K$108.58−$434.3K−7.7%48.0K after2 lots10b5-1
Nov 26, 2025 (view filing)Nov 242 daysShair MatthewDirectorSSaleClass A Common Stock−5.85K$109.37−$639.8K−0.4%1.38M after4 lots10b5-1
Nov 26, 2025 (view filing)Nov 242 daysShair MatthewDirectorSSaleClass A Common Stock−1.65K$109.37−$180.5K−0.8%201.7K after4 lots10b5-1
Nov 24, 2025 (view filing)8:00 PM ETNov 24Same dayDeerfield Management Company, L.P. and 7 othersDirector, 10% Owner, Other: Director by DeputizationSSaleClass A Common Stock−742.6K$95.45−$70.9M−8.2%8.30M after2 lots
Nov 19, 2025 (view filing)Nov 17-182 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−20.7K$99.62−$2.07M−25.1%61.7K after8 lots10b5-1
Nov 19, 2025 (view filing)Nov 172 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−24.2K$105.50−$2.55M−33.0%49.1K after3 lots10b5-1
Oct 31, 2025 (view filing)Oct 301 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.00K$102.92−$411.7K−7.7%48.0K after6 lots10b5-1
Oct 31, 2025 (view filing)Oct 301 dayMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−21.8K$103.16−$2.25M−30.8%49.1K after8 lots10b5-1
Oct 29, 2025 (view filing)Oct 27-282 daysShair MatthewDirectorSSaleClass A Common Stock−46.8K$100.26−$4.69M−3.3%1.38M after2 lots10b5-1
Oct 29, 2025 (view filing)Oct 27-282 daysShair MatthewDirectorSSaleClass A Common Stock−13.2K$100.26−$1.32M−6.1%203.3K after2 lots10b5-1
Oct 22, 2025 (view filing)Oct 202 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−5.00K$94.91−$474.6K−9.2%49.1K after10b5-1
Oct 17, 2025 (view filing)Oct 161 dayPorter James RichardPresident and CEOSSaleClass A Common Stock−27.0K$90.63−$2.45M−9.8%249.1K after4 lots10b5-1
Oct 17, 2025 (view filing)Oct 15-162 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−28.0K$90.72−$2.54M−36.3%49.1K after4 lots10b5-1
Oct 17, 2025 (view filing)Oct 152 daysPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−14.2K$90.04−$1.28M−17.7%66.0K after10b5-1
Oct 17, 2025 (view filing)Oct 152 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−1.68K$85.57−$144.0K−2.7%61.7K after10b5-1